EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4

Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday.

Intelligent Bio Solutions is a medical technology company delivering intelligent, rapid, noninvasive testing solutions.

“Fiscal 2025 represented a year of disciplined execution and strategic investment. For the fiscal fourth quarter, we expect to report another quarter of sequential and year-over-year revenue growth,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions.

Also Read: EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based ...